
Please try another search
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, the company offers medical aesthetics products, including Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, it is involved in the research and development, consultation, and services of biological engineering and pharmaceutical products, and related technology transfer activities; manufacture and sale of biological reagents, biologicals, and biological materials; manufacture and sale of intraocular lens and related products; sale machines of medical aesthetics, professional life cosmetology, and home cosmetology; sale of ophthalmology products; and provision of other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Jianying Wu | 57 | 2010 | GM & Executive Director |
Minjie Tang | 46 | 2016 | CFO & Executive Director |
Yongtai Hou | 59 | 2010 | Executive Chairman |
Yiyi Chen | 39 | 2010 | Executive Director |
Jie You | 62 | 2010 | Non Executive Director |
Hongbo Shen | 46 | 2023 | Independent Non-Executive Director |
Zhi Su | 48 | 2020 | Independent Non-Executive Director |
Yushe Yang | 62 | 2020 | Independent Non-Executive Director |
Ming Ping Huang | 49 | 2010 | Non-Executive Director |
Changzheng Wei | 45 | 2010 | Non-Executive Director |
Zhihong Jiang | 57 | 2020 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review